Citigroup’s Agile Therapeutics, Inc AGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-181
| Closed | -$353 | – | 5038 |
|
|
2023
Q4 | $353 | Hold |
181
| – | – | ﹤0.01% | 4703 |
|
|
2023
Q3 | $436 | Hold |
181
| – | – | ﹤0.01% | 4464 |
|
|
2023
Q2 | $534 | Sell |
181
-1
| -0.5% | -$3 | ﹤0.01% | 4616 |
|
|
2023
Q1 | $2.04K | Sell |
182
-2
| -1% | -$22 | ﹤0.01% | 4370 |
|
|
2022
Q4 | $2.09K | Buy |
184
+2
| +1% | +$23 | ﹤0.01% | 4461 |
|
|
2022
Q3 | $3K | Sell |
182
-989
| -84% | -$16.3K | ﹤0.01% | 4648 |
|
|
2022
Q2 | $68K | Buy |
1,171
+1,159
| +9,658% | +$67.3K | ﹤0.01% | 3730 |
|
|
2022
Q1 | $5K | Buy |
12
+8
| +200% | +$3.33K | ﹤0.01% | 5042 |
|
|
2021
Q4 | $4K | Hold |
4
| – | – | ﹤0.01% | 4917 |
|
|
2021
Q3 | $7K | Hold |
4
| – | – | ﹤0.01% | 4798 |
|
|
2021
Q2 | $10K | Sell |
4
-2
| -33% | -$5K | ﹤0.01% | 5005 |
|
|
2021
Q1 | $25K | Sell |
6
-4
| -40% | -$16.7K | ﹤0.01% | 4459 |
|
|
2020
Q4 | $58K | Sell |
10
-2
| -17% | -$11.6K | ﹤0.01% | 4011 |
|
|
2020
Q3 | $73K | Sell |
12
-3
| -20% | -$18.3K | ﹤0.01% | 3296 |
|
|
2020
Q2 | $83K | Sell |
15
-2
| -12% | -$11.1K | ﹤0.01% | 3565 |
|
|
2020
Q1 | $62K | Buy |
+17
| New | +$62K | ﹤0.01% | 3625 |
|
|
2017
Q2 | – | Sell |
-1
| Closed | -$5K | – | 5025 |
|
|
2017
Q1 | $5K | Sell |
1
-1
| -50% | -$5K | ﹤0.01% | 4485 |
|
|
2016
Q4 | $20K | Buy |
+2
| New | +$20K | ﹤0.01% | 4390 |
|
|
2016
Q2 | – | Sell |
-5
| Closed | -$58K | – | 5378 |
|
|
2016
Q1 | $58K | Buy |
+5
| New | +$58K | ﹤0.01% | 4221 |
|
|
2015
Q4 | – | Hold |
0
| – | -$4K | – | 5175 |
|
|
2015
Q3 | – | Hold |
0
| – | -$1K | – | 4746 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 5397 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 5722 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 5661 |
|